234 related articles for article (PubMed ID: 20868587)
1. Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab.
Leccese P; D'Angelo S; Angela P; Coniglio G; Olivieri I
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S102. PubMed ID: 20868587
[No Abstract] [Full Text] [Related]
2. Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Behçet's disease.
Belzunegui J; López L; Paniagua I; Intxausti JJ; Maíz O
Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S133-4. PubMed ID: 19026138
[No Abstract] [Full Text] [Related]
3. Successful treatment of recalcitrant genital ulcers of Behçet's disease with adalimumab after failure of infliximab and etanercept.
Olivieri I; D' Angelo S; Padula A; Leccese P; Mennillo GA
Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S112. PubMed ID: 19796550
[No Abstract] [Full Text] [Related]
4. Adalimumab: a new modality for Behçet's disease?
van Laar JA; Missotten T; van Daele PL; Jamnitski A; Baarsma GS; van Hagen PM
Ann Rheum Dis; 2007 Apr; 66(4):565-6. PubMed ID: 17124248
[No Abstract] [Full Text] [Related]
5. Successful switching to adalimumab in an infliximab-allergic patient with severe Behçet disease-related uveitis.
Takase K; Ohno S; Ideguchi H; Uchio E; Takeno M; Ishigatsubo Y
Rheumatol Int; 2011 Feb; 31(2):243-5. PubMed ID: 19816689
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of leg ulcers in Behçet's disease using adalimumab plus methotrexate after the failure of infliximab.
Atzeni F; Leccese P; D'Angelo S; Sarzi-Puttini P; Olivieri I
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S94. PubMed ID: 20868581
[No Abstract] [Full Text] [Related]
7. Successful treatment of refractory neuro-Behcet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile.
Fujikawa K; Aratake K; Kawakami A; Aramaki T; Iwanaga N; Izumi Y; Arima K; Kamachi M; Tamai M; Huang M; Nakamura H; Nishiura Y; Origuchi T; Ida H; Eguchi K
Ann Rheum Dis; 2007 Jan; 66(1):136-7. PubMed ID: 17178762
[No Abstract] [Full Text] [Related]
8. Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet's disease.
Sugimura N; Mizoshita T; Sugiyama T; Togawa S; Miyaki T; Suzuki T; Tanida S; Kataoka H; Sasaki M
Dig Liver Dis; 2019 Jul; 51(7):967-971. PubMed ID: 30872086
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab.
Leccese P; Latanza L; D'Angelo S; Padula A; Olivieri I
Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S93. PubMed ID: 21813069
[No Abstract] [Full Text] [Related]
10. Adalimumab for sight-threatening uveitis in Behçet's disease.
Mushtaq B; Saeed T; Situnayake RD; Murray PI
Eye (Lond); 2007 Jun; 21(6):824-5. PubMed ID: 16601736
[TBL] [Abstract][Full Text] [Related]
11. Effect of infliximab on refractory uveitis in Behcet's disease.
Sayarlioglu M; Cinal A; Topcu N; Demirok A
Ann Pharmacother; 2004 May; 38(5):901-2. PubMed ID: 15010522
[No Abstract] [Full Text] [Related]
12. Successful treatment of genital ulcers with infliximab in Behcet's disease.
Haugeberg G; Velken M; Johnsen V
Ann Rheum Dis; 2004 Jun; 63(6):744-5. PubMed ID: 15140785
[No Abstract] [Full Text] [Related]
13. Intestinal Behçet's disease: maintenance of remission with adalimumab monotherapy.
Ariyachaipanich A; Berkelhammer C; Nicola H
Inflamm Bowel Dis; 2009 Dec; 15(12):1769-71. PubMed ID: 19177427
[No Abstract] [Full Text] [Related]
14. Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet's Disease.
Park J; Cheon JH
Gut Liver; 2018 Nov; 12(6):623-632. PubMed ID: 29788675
[TBL] [Abstract][Full Text] [Related]
15. Intra-articular anti-tumor necrosis factor alpha antibody in recalcitrant arthritis of Behçet's disease.
Andonopoulos AP; Meimaris N; Daoussis D; Bounas A; Yiannopoulos G
Clin Exp Rheumatol; 2003; 21(4 Suppl 30):S57-8. PubMed ID: 14727465
[No Abstract] [Full Text] [Related]
16. [Treatment of severe Behçet's disease with anti-TNF-alpha: infliximab. A case report].
Andreu M; Ramanoelina J; Fajnkuchen F; Mouthon L; Cohen P; Laroche L; Guillevin L
Ann Med Interne (Paris); 2002 Oct; 153(6):414-5. PubMed ID: 12486393
[No Abstract] [Full Text] [Related]
17. Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature.
Pipitone N; Olivieri I; Padula A; D'angelo S; Nigro A; Zuccoli G; Boiardi L; Salvarani C
Arthritis Rheum; 2008 Feb; 59(2):285-90. PubMed ID: 18240181
[No Abstract] [Full Text] [Related]
18. Infliximab in refractory uveitis due to Behçet's disease.
Wechsler B; Sablé-Fourtassou R; Bodaghi B; Huong DL; Cassoux N; Badelon I; Fain O; LeHoang P; Piette JC
Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S14-6. PubMed ID: 15515776
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of adalimumab in patients with Behçet's disease unsuccessfully treated with infliximab.
Olivieri I; Leccese P; D'Angelo S; Padula A; Nigro A; Palazzi C; Coniglio G; Latanza L
Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S54-7. PubMed ID: 21968237
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of a single dose of infliximab in the treatment of Behçet's disease uveitis.
Arayssi T; Hamra R; Homeidan F; Uthman I; Awwad ST; Mroue K; Mansour W; Bashshur ZF
Clin Exp Rheumatol; 2005; 23(3):427. PubMed ID: 15971438
[No Abstract] [Full Text] [Related]
[Next] [New Search]